Available Technologies

Browse Penn-owned technologies available for licensing.

HOME SEARCH RSS FEED

Search Results - covid-19

12 Results Sort By:

Rapid pathogen diagnostic through amplification of red blood cell-associated DNA

Problem: Sepsis, an overwhelming and life-threatening response to infection, is the most common cause of death in US hospitals. Sepsis is associated with a mortality rate of 25–30% and mortality due to septic shock is 50–85%. Rapid diagnosis and intervention in sepsis are essential given an increased mortality rate of 8% for every hour...

Published: 11/24/2020

Inventor(s):

Keywords(s):

Category(s):

Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings

A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time of hours...

Published: 11/11/2020

Inventor(s):

Keywords(s):

Category(s):

Low-cost rapid diagnostic for COVID-19

A COVID-19 diagnostic approach, utilizing a SARS-CoV-2 binding biosensor, that allows for real-time virus detection, without the need for sample processing, ultimately leading to population-level surveillance, outbreak tracking, reduced healthcare costs, improved treatment outcomes, and saved lives. Problem: SARS-CoV-2, the virus that causes COVID-19,...

Published: 11/5/2020

Inventor(s):

Keywords(s):

Category(s):

Ultra-fast killing of SARS-CoV-2 and enveloped viruses with a dental irrigation solution

A mixture has been identified that can rapidly deactivate SARS-CoV-2 and similar viruses for use during dental office procedures to prevent viral transmission. Problem: During routine dental procedures, aerosolized droplets containing water, a patient’s saliva and blood, microorganisms and other debris are produced as a result of commonly used...

Published: 8/20/2020

Inventor(s):

Keywords(s):

Category(s):

Targeted drug delivery using red-blood cells for transport

Platform technology for targeted drug delivery using red blood cells for transport. Problem: Drug delivery can often result in up to 99% of the drug being delivered to off-target organs. This can lead to side-effects and toxicities. Current methods that bind drugs to red-blood cells for transport can require modifying the structure of the red blood...

Published: 6/23/2020

Inventor(s):

Keywords(s):

Category(s):

Device for MRI scanner intra-bore disinfection

Magnetic field-safe device for rapid disinfection of MRI bore and other types of scanners (CT, PET, PET-MR, SPECT) that is effective against COVID19, MRSA and other pathogens.</rss.brief Problem: With the advent of COVID-19, renewed emphasis has been placed on disinfecting surfaces in the medical environment. Disinfecting the MRI scanner bore...

Published: 6/23/2020

Inventor(s):

Keywords(s):

Category(s):

Protein drugs encapsulated in plant cells as low-cost prevention and treatment of lung injury in COVID-19 patients

Use of functional recombinant ACE2 and Angiotensin-(1-7) proteins to improve the clinical course of patients with symptomatic COVID-19 infection. Problem: COVID-19 is associated with high rates of respiratory failure, cardiac injury and death. Patients suffering from COVID-19 generally present with reduced expression of angiotensin converting enzyme...

Published: 6/2/2020

Inventor(s):

Keywords(s):

Category(s):

Lipid nanoparticle-based mRNA delivery for CAR T-cell engineering

A library of ionizable lipid nanoparticles (LNPs) was screened for ability to deliver mRNA to T-cells, leading to an optimized LNP formulation for delivery of mRNA to T-cells. This thereby enhances the ability to generate transient chimeric antigen receptor (CAR)-expressing T-cells for cancer immunotherapy.Problem: Chimeric antigen receptor (CAR) T-cells...

Published: 5/4/2020

Inventor(s):

Keywords(s):

Category(s):

Rapid method to design and screen novel lipid nanoparticles for mRNA delivery in vivo

A platform technology to rapidly identify novel lipid nanoparticle (LNP) formulations to carry mRNA-based therapeutics to target organs/cells in vivo. Problem: Messenger RNA (mRNA) has emerged as a promising new class of nucleic acid therapy, with the potential to induce protein production to treat and prevent a range of diseases. While significant...

Published: 5/4/2020

Inventor(s):

Keywords(s):

Category(s):

Improving drug delivery using red blood cell hitchhiking

style> Problem: A major challenge in drug delivery is ensuring that the drug reaches the target organ at a concentration sufficient to treat the disease. This is particularly problematic for acute illnesses of the vasculature, such as acute respiratory distress syndrome (ARDS), ischemic stroke, and myocardial infarction. In these diseases, patients...

Published: 2/13/2020

Inventor(s):

Keywords(s):

Category(s):

1 2